SAN FRANCISCO, May 15, 2019 /PRNewswire/ -- The global ivd quality control market size is expected to reach USD 1.24 billion by 2026, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 4.1% over the forecast period. Continually evolving technology-oriented changes in the diagnostics field and growing need to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and Point-of-Care (PoC) devices. Patients rely on self-testing IVD devices for long-term disease management and hence it is important for such devices to be checked, in terms of result reproducibility and validity, to guarantee patient safety.

Key suggestions from the report:

• In 2018, the clinical chemistry was the second-largest application segment of the global IVD market, in terms of market share
• Demand for preventive medicine and rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for the segment's growth
• Molecular diagnostics is projected to be the fastest-growing segment due to increasing technical complexity of molecular diagnostic testing and need for quality evaluation to ensure standards
• These tests are of prime importance as the outcomes enable healthcare practitioners make critical treatment decisions
• Hospitals was the largest segment in 2018 due to the presence of advanced technology-based devices like Next Generation Sequencing (NGS) and microarrays, and rising applications of the optimized quality-control procedures
• North America was the dominant regional market in 2018 due to the presence of over 150,000 registered diagnostics labs and is likely to maintain the dominance throughout the forecast years
• Siemens Healthcare GmbH; Roche Diagnostics; Alere, Inc.; Abbott Laboratories, Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Quidel Corp.; Becton, Dickinson and Company; bioMerieux, Inc.; Sysmex Corp.; Sero AS; and Thermo Fisher Scientific, Inc. are some of the key companies in the global market

Read 185 page research report with TOC on "In Vitro Diagnostics Quality Control Market Size, Share & Trends Analysis Report By Application, By Type (Quality Control, Quality Assurance Services), By End Use (Lab, Home-care, Hospital), And Segment Forecasts, 2019 - 2026" at: https://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market

Rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the market. In addition to quality assessments, amendments to the regulatory framework are made intermittently to enhance the existing standards with the main objective of safeguarding qualitative superiority of the diagnostic services. In May 2016, the European Union passed an agreement to update the pre-existing regulations pertaining to IVD devices, wherein the updates were in concern with raising the patient safety levels, particularly for disabled persons. The presence of third-party agencies for independent assessment of the IVD devices is expected to elevate the current safety standards, which will drive the In Vitro Diagnostics (IVD) Quality Control market further.

Grand View Research has segmented the global IVD quality control market on the basis of application, type, end use, and region:

• IVD Quality Control Application Outlook (Revenue, USD Million, 2014 - 2026)
• Immunochemistry
• Hematology
• Clinical Chemistry
• Molecular Diagnostics
• Coagulation
• Microbiology
• Others
• IVD Quality Control Type Outlook (Revenue, USD Million, 2014 - 2026)
• Quality Control
• Quality Controls, by Type
• Plasma-based Control
• Serum-based Control
• Whole Blood-based Control
• Others
• Quality Controls, by Application
• Immunochemistry
• Hematology
• Clinical Chemistry
• Molecular Diagnostics
• Coagulation
• Microbiology
• Others
• Quality Assurance Services
• Immunochemistry
• Hematology
• Clinical Chemistry
• Molecular Diagnostics
• Coagulation
• Microbiology
• Others
• Data Management
• Clinical Chemistry
• Immunochemistry
• Hematology
• Molecular Diagnostics
• Coagulation
• Microbiology
• Others
• IVD Quality Control End Use Outlook (Revenue, USD Million, 2014 - 2026)
• Hospitals
• Laboratories
• Home-care
• Others
• IVD Quality Control Regional Outlook (Revenue, USD Million, 2014 - 2026)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Spain
• Italy
• Russia
• Asia Pacific
• Japan
• China
• India
• South Korea
• Singapore
• Australia
• Latin America
• Brazil
• Argentina
• MEA
• South Africa
• UAE
• Saudi Arabia

Find more research reports on Clinical Diagnostics Industry, by Grand View Research:

• G-Protein Coupled Receptors (GPCRs) Market – The G-protein coupled receptors (GPCRs) market is expected to witness a lucrative growth during the forecast period owing to the major factors such as increasing demand of GPCRs in ADME toxicity studies
• Atrial Septal Defect Market – Increasing disposable income of the Asian population would boost or increase the growth of arterial septal defect market in the years to come.
• Blood Cell Factors Market – If blood cell counts are low, then the drug given by the doctor is termed as a blood cell growth factor to stimulate the blood cell production. The body normally makes blood cell with the help of a hormone produced in the kidneys, called erythropoietin (EPO).

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter

SOURCE Grand View Research, Inc.